OR WAIT null SECS
There is a great need for sensitive, precise, and easily accessible analytical detection techniques for protein sequencing.
The emergence of mRNA vaccines and cell and gene therapies has pushed innovation in analytical methods.
Effective analytics will eliminate failures, deviations, and non-conformances.
August 20, 2009
Also, XCELERON and GSK form agreement; Millipore appoints VP of life sciences; more...
August 13, 2009
Also: DSM's North Carolina facility receives SafeBridge certification; Dynavax CFO to retire; more...
August 06, 2009
Also, Pfizer forms two research agreements in China; NanoInk appoints John Kubricky to its scientific advisory board; more...
The US Food and Drug Administration and European Medicines Agency (EMEA) launched this week a joint initiative to collaborate on international good clinical practice (GCP) inspection activities.
August 02, 2009
Editors' Picks of Pharmaceutical Science & Technology Innovations
Brief pharmaceutical news items for August 2009.
Biotech firms must first close the gaps between science and biology on the path toward QbD.
The author of an ambitious book about quality control falls short of reaching his goals.
The authors applied near-infrared (NIR) spectrophotometry to assess whether eight drug products were authentic or counterfeit.
Individuals and companies at the top seem to have no problem short-circuiting their success.